Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Fernas
    Member
    • Apr 2013
    • 74

    Ambiguous Reads Treatment by HTSeq-Count

    Currently, if a person uses HTSeq-Count to count reads on transcript level and the tool finds a read that overlaps two overlapped transcripts (this is very common) then the tool will identify the read as ambiguous and will not include it in the counting process. As the author assumed, this is useful for identification of differentially expressed genes. However, this approach will underestimate the expression of overlapping transcripts and overestimate unique ones.

    Can we modify somehow HTSeq-Count to include such reads? any other tools that overcome such situation?
  • dpryan
    Devon Ryan
    • Jul 2011
    • 3478

    #2
    htseq-count isn't intended for that use, so while you could modify it, why both? You can get featureCounts to do this, but you really need to be careful about what you then do with these counts. If you're going to use these in something like DESeq2 or edgeR then you're simply doing it wrong (you'll just simply get wrong results).

    In general, transcript abundance is better estimated with an expectation maximization algorithm (e.g. FluxCapacitor, or eXpress).

    Comment

    • Fernas
      Member
      • Apr 2013
      • 74

      #3
      Thank you very much @dpryan for the very informative reply. I will have a look into these tools.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 11:41 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-20-2026, 11:10 AM
      0 responses
      23 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-13-2026, 10:26 AM
      0 responses
      35 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Working...